Article info

Download PDFPDF

Original research article
High incidence of atrial fibrillation in patients treated with ibrutinib

Authors

  • Florian Baptiste Department of Cardiology, Unit of Heart Failure and Valvular Heart Diseases, Mediterranean University Cardio-Oncology Center (MEDI-CO Center), Hôpital Nord, Aix-Marseille I University, Marseille, France PubMed articlesGoogle scholar articles
  • Jennifer Cautela Department of Cardiology, Unit of Heart Failure and Valvular Heart Diseases, Mediterranean University Cardio-Oncology Center (MEDI-CO Center), Hôpital Nord, Aix-Marseille I University, Marseille, France PubMed articlesGoogle scholar articles
  • Yan Ancedy Université Pierre et Marie Curie, Paris, France PubMed articlesGoogle scholar articles
  • Noémie Resseguier Biostatistic and Public Healt Department, Hopital de la Timone, Marseille, France PubMed articlesGoogle scholar articles
  • Thérèse Aurran Department of Haematology, Institut Paoli-Calmettes, Marseille, France PubMed articlesGoogle scholar articles
  • Laure Farnault Department of Haematology, Aix-Marseille I University, Marseille, France PubMed articlesGoogle scholar articles
  • Marion Escudier Department of Cardiology, Unit of Heart Failure and Valvular Heart Diseases, Mediterranean University Cardio-Oncology Center (MEDI-CO Center), Hôpital Nord, Aix-Marseille I University, Marseille, France PubMed articlesGoogle scholar articles
  • Chloé Ammar Department of Cardiology, Unit of Heart Failure and Valvular Heart Diseases, Mediterranean University Cardio-Oncology Center (MEDI-CO Center), Hôpital Nord, Aix-Marseille I University, Marseille, France PubMed articlesGoogle scholar articles
  • Mélanie Gaubert Department of Cardiology, Unit of Heart Failure and Valvular Heart Diseases, Mediterranean University Cardio-Oncology Center (MEDI-CO Center), Hôpital Nord, Aix-Marseille I University, Marseille, France PubMed articlesGoogle scholar articles
  • Charles Dolladille PICARO Cardio-oncology Program, Department of Pharmacology, CHRU de Caen, Caen, France PubMed articlesGoogle scholar articles
  • Jeremie Barraud Department of Cardiology, Unit of Heart Failure and Valvular Heart Diseases, Mediterranean University Cardio-Oncology Center (MEDI-CO Center), Hôpital Nord, Aix-Marseille I University, Marseille, France PubMed articlesGoogle scholar articles
  • Michael Peyrol Department of Cardiology, Unit of Heart Failure and Valvular Heart Diseases, Mediterranean University Cardio-Oncology Center (MEDI-CO Center), Hôpital Nord, Aix-Marseille I University, Marseille, France PubMed articlesGoogle scholar articles
  • Ariel Cohen Université Pierre et Marie Curie, Paris, France PubMed articlesGoogle scholar articles
  • Franck Paganelli Department of Cardiology, Unit of Heart Failure and Valvular Heart Diseases, Mediterranean University Cardio-Oncology Center (MEDI-CO Center), Hôpital Nord, Aix-Marseille I University, Marseille, France PubMed articlesGoogle scholar articles
  • Joachim Alexandre PICARO Cardio-oncology Program, Department of Pharmacology, CHRU de Caen, Caen, France PubMed articlesGoogle scholar articles
  • Stephane Ederhy Université Pierre et Marie Curie, Paris, France PubMed articlesGoogle scholar articles
  • Franck Thuny Department of Cardiology, Unit of Heart Failure and Valvular Heart Diseases, Mediterranean University Cardio-Oncology Center (MEDI-CO Center), Hôpital Nord, Aix-Marseille I University, Marseille, France PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Franck Thuny; franck.thuny{at}gmail.com
View Full Text

Citation

Baptiste F, Cautela J, Ancedy Y, et al
High incidence of atrial fibrillation in patients treated with ibrutinib

Publication history

  • Received March 11, 2019
  • Revision received April 2, 2019
  • Accepted April 14, 2019
  • First published May 8, 2019.
Online issue publication 
May 08, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.